Milliporesigma Brochures

  1. Mobius® Power MIX 1000 And 2000 Single-Use Mixers 1/4/2018

    The Mobius® Power MIX 1000 and 2000 combine high performance mixing technology with design features that make them easy to use. The impeller design and motor are based on our magnetically coupled NovAseptic® mixing technology, a proven mixing technology in stainless steel tanks. The system efficiently mixes the most challenging buffers, media and biopharmaceutical ingredients.

  2. Gene Therapy Capabilities For AAV And Lentivirus Production

    Explore all of our gene therapy solutions for AAV and Lentivirus manufacturing based on 30+ years of experience to help bring your therapy to life. 

  3. A Versatile And Modality-Agnostic Aseptic Autosampling Solution

    Discover a versatile and modality-agnostic aseptic autosampling solution designed for reliable on-line sample analysis in near real-time without the need for manual intervention.

  4. VirusExpress 293 AAV Production Platform

    The VirusExpress® Platform offers a transfection-based solution to Adeno-Associated Viral (AAV) production challenges, featuring a suspension adapted cell line, chemically defined medium, and a clinically relevant process dramatically reducing time to commercial production.

  5. Comprehensive Solutions For Your Vaccine Platforms

    Vaccine production, from process development to full-scale GMP-manufacturing, must be efficient, safe, and cost-effective. Learn how our global capabilities can help you achieve these goals for all your modalities/platforms.

  6. Roadmap To Success: Viral Clearance Services

    Accessibility and availability of viral clearance services are critical when it comes to on-time filing with regulators. Explore a solution that supports your clearance needs.

  7. Analytical Development And Characterization For AAV

    Our assay packages and phase-appropriate assay development and validation capabilities provide the product and process knowledge you need to develop a QTPP and identify the CQAs for your therapy.

  8. Optimization Of Benzonase® Endonuclease Use In Virus Purification

    The use of Benzonase® endonuclease additionally increases the yield in virus purification, protects the downstream chromatography and filter devices from fouling and reduces feed stream viscosity. In this document we will provide you guidance on how to plan and set up a Design of Experiments (DoE) optimization experiment of Benzonase® endonuclease in your viral gene therapy process.

  9. AAV Biosafety Testing & Characterization Services

    Biosafety testing and characterization for new products are essential as they emerge for clinical study. Both measures will help mitigate safety concerns and confirm product quality before these therapies are administered to patients. Our BioReliance® AAV testing services give you the confidence to get your products to market quickly and safely.

  10. Medium For Producing High AAV Titers In Multiple HEK293 Cell Lines

    Discover a chemically defined medium optimized for AAV production that has been streamlined and cell culture media components incorporated to increase media stability and reduce protein oxidation.